A population-based analysis looking at almost 13,000 cases revealed that men who received brachytherapy alone or in combination with external beam radiation therapy had significantly reduced mortality rates.

After a 20-year quest to find a genetic driver for prostate cancer that strikes men at younger ages and runs in families, researchers have identified a rare, inherited mutation linked to a significantly higher risk of the disease.

After a 20-year quest to find a genetic driver for prostate cancer that strikes men at younger ages and runs in families, researchers have identified a rare, inherited mutation linked to a significantly higher risk of the disease.

Researchers found that a significant number of women evaluated at six-month intervals did not recognize recent gains in weight. Self-perception of weight gain appears to be significantly influenced by race, ethnicity and contraceptive methods.

A certain omega-3 fatty acid is necessary to construct the arch that turns a round, immature sperm cell into a pointy-headed super swimmer with an extra long tail, according to new research. The study shows that docosahexaenoic acid is essential in fusing the building blocks of the acrosome together. The acrosome is critical in fertilization because it houses, organizes, and concentrates a variety of enzymes that sperm use to penetrate an egg.

Researchers created a drug delivery system that is able to effectively deliver a tremendous amount of chemotherapeutic drugs to prostate cancer cells.

Researchers have developed a new way to identify the genes of harmful microbes, particularly those that have been difficult to study in the laboratory.

Environmental exposure to organochlorine chemicals, including polychlorinated biphenyls (PCBs) and p,p'-DDE (the main metabolite of the insecticide DDT) can affect male reproduction, according to new research.

Researchers recently found that obesity was linked to higher rates of prostate cancer screening across all races/ethnic differences and lower rates of cervical cancer screening, most notably in white women.

There's new evidence that annual prostate cancer screening does not reduce deaths from the disease, even among men in their 50s and 60s and those with underlying health conditions, according to new research.